RESCON EUROPE highlights innovations in the respiratory sector and connected devices. RESCON EUROPE will feature key case studies on the latest trends in Sustainable Inhalation devices, Inhaled mRNA Therapy, from inhaled insulin to gene therapy to overcome lung and pulmonary conditions, such as COPD, asthma and cystic fibrosis. Further discussion focusses at on-body device design and development for large volume delivery while engaging in the latest digital applications for wearable devices.
The 2-day inhalation & respiratory drug delivery | connected devices event will begin in Porto, Portugal at the World of Wine on Monday, June 20th with opening remarks from Joana Roque Vice-president of Associação Nacional de Fibrose Quística before heading in the packed agenda featuring experts from around the industry. Berry Global’s Marco Franza, Sales & Business Development Director for Global Inhalation & Medical Devices will be presenting from 11:30 - 12:00 sharing his insights on ‘Aiming to the balance point: Thinking Next Generation DPIs.”